entertainment -WSS

entertainment

author：focus 2025-09-06 04:28:39 - browse：892

Adobe

You didn’t need machine learning to make one prediction about the year’s biggest conference for health care investors, which was held in San Francisco last week. It was going to rain.

Recursion, a biotechnology firm that uses machine learning for drug development and that was announcing that it is rolling out AI-driven drug discovery software with tech giant Nvidia, decided to seize the moment. As the heavens opened, Recursion employees handed out black umbrellas emblazoned with the Recursion logo and lined with neon images of cells. It was one of a series of publicity grabs from the company, including a satellite event featuring Nvidia’s famous CEO, Jensen Huang, who has become a Wall Street rock star as his company’s stock has exploded due to rising expectations for AI, reaching a $1 trillion market value, the sixth highest in the world.

Seeing the square outside the Westin St. Francis, where the J.P. Morgan Healthcare Conference has been held for 42 years, fill with Recursion’s umbrellas was a little like seeing the message that AI was ready for its debut come to life. But it was also true that not everyone was ready to embrace that message.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Telehealth for opioid use disorder is lifesaving

focus

WSS

New weight loss drugs vying to be the next Wegovy or Mounjaro

Acelyrin, a rare IPO success, stumbles in its first big test

Diverse clinical trials: Why aren’t we there yet?

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Long Covid needs a new name — and a new frame

Drinking water from half of US faucets contains PFAS: Study

focus

entertainment

focus

Anesthesiologist group: stop taking Ozempic before surgery

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

George Santos makes 1st court appearance after pleading not guilty to 13 counts

New weight loss drugs vying to be the next Wegovy or Mounjaro

New air purifier tech could be key to improving indoor air quality

New weight loss drugs vying to be the next Wegovy or Mounjaro

Anesthesiologist group: stop taking Ozempic before surgery

Generate Biomedicines machine learning biotech raises $273M

Hollywood unions extend contract negotiations for actors

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

focus

FDA proposes changes to key medical devices approval pathway

IRA could hurt research into orphan drugs for rare diseases

House panel to mark up pandemic

How housing is health care on Long Island

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

With fresh data, a dynamic duo powers Eli Lilly to new heights

focus

hotspot

Wikipedia

explore